Arcus acquired a majority stake in FixMap in September Net is the second add-on under Arcus’ ownership FixMap is a Polish FTTH operator founded in 2018 Arcus Infrastructure Partners portfolio ...

Arcus Biosciences, Inc. (NYSE: RCUS) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Pia Eaves - VP, IR Terry Rosen - CEO Richard Markus - CMO Jennifer Jarrett - COO ...

Arcus Biosciences (NYSE:RCUS) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Arcus ...

Arcus Biosciences Inc. (NYSE: RCUS) shares are trading lower Tuesday after the company announced a $150 million common stock offering.

HAYWARD, Calif., February 18, 2025--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies ...

A new report out today from anti-ransomware and cyber resilience platform provider Halcyon Tech Inc. details the increasingly sophisticated techniques used by the Arcus Media ransomware group. Not ...

With new data on Arcus' HIF-2a inhibitor, one group of analysts figures the company could give Merck’s Welireg a run for its money in kidney cancer.

Arcus to keep FixMap’s ‘M&A machine’ rolling as pipeline looks strong The private equity firm bought FixMap, a Warsaw-based fiber-to-the-home business, in mid-September.

Collins Aerospace, an RTX business, has developed a new image generator (IG) called Arcus and launched it in November at the Interservice/Industry Training, Simulation ...

Arcus (RCUS) surges as it expands its previous research collaboration with partner Gilead, to focus on developing therapies for inflammatory diseases.

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...